
Novel, High-Efficiency and Clean Plasma Focus Radioactive-Beam Ion-Source for Applications in Nuclear Research and BiomedicineAward last edited on: 4/1/2002
Sponsored Program
SBIRAwarding Agency
DOETotal Award Amount
$849,066Award Phase
2Solicitation Topic Code
-----Principal Investigator
Jan S BrzoskoCompany Information
Diana Hi-Tech LLC (AKA: Detection & Instrumentation For Advanced Neutron Applications, Llc)
55 Hiddenledge Road
Englewood, NJ 07631
Englewood, NJ 07631
(201) 332-2962 |
N/A |
N/A |
Location: Single
Congr. District: 09
County: Bergen
Congr. District: 09
County: Bergen
Phase I
Contract Number: ----------Start Date: ---- Completed: ----
Phase I year
2000Phase I Amount
$99,847Commercial Applications and Other Benefits as described by the awardee:
Two fold commercial applications are identified: (a) Rare Isotopes Beams source used in nuclear research. Due to low cost (four times) of the breeder and higher intensity of ions (thousands times), as compared to the current and projected beam intensity, will increase the capabilities of ORNL and open research in at least six university accelerators, two National Labs. in US and many other international research centers. (b) Biomedicine and PET-scan. The cost for production (with Plasma Focus) of short live radioisotopes (11C, 13N, 15O, 18F) used in medical diagnostics will be three times lower and with increased radiation safety and lower maintenance costs, as compared to current systems using cyclotrons. This will open up accessibility to PET scanning technology. The projected number of PET centers is expected to double by 2003 to 250 in the U.S. and 175 abroad. We intend to market our Rare Isotopes ion source and dominate medical market for short-lived isotopes, providing fast delivery of 18F-based tracers; and installing and providing services at hospitals/centers using 11C, 13N, 15O.
Phase II
Contract Number: ----------Start Date: ---- Completed: ----
Phase II year
2001Phase II Amount
$749,219Commercial Applications and Other Benefits as described by the awardee:
Commercial applications include rare isotopes beams used in nuclear/astrophysical research, biomedicine, and PETscan. With Plasma Focus the cost of production, of short live radioisotopes (11C, 13N, 15O, 18F) used in medical diagnostics should be three times lower. Additional competitive advantages, compared to current systems using cyclotrons, include no neutron radiation, no radio-material waste along the reprocessing line, and lower maintenance costs.